Table 3

 Difference between control and intervention in biomedical markers of cardiovascular disease at 12 months in the trial of the DESMOND programme

nMean (95% CI) cluster adjusted difference (intervention − control)
HbA1c (%)7150.060 (−0.097 to 0.217)
Total cholesterol (mmol/l)709−0.044 (−0.201 to 0.114)
High density lipoprotein cholesterol (mmol/l)5260.015 (−0.043 to 0.073)
Systolic blood pressure (mm Hg)7270.984 (−1.800 to 3.768)

DESMOND, diabetes education and self management for ongoing and newly diagnosed; HbA1c, glycated haemoglobin.